Bias, Corruption & Accountability

Suicide Rates Rise While Antidepressant Use Climbs

16
Multiple media sources are reporting on new data from the CDC revealing a substantial increase in the suicide rate in the United States between 1999...

Adverse Effects: The Perils of Deep Brain Stimulation for Depression

51
Hundreds of people have been given remote control deep brain stimulation implants for psychiatric disorders such as depression, OCD and Tourette’s. Yet DBS specialists still have no clue about its mechanisms of action and research suggests its hefty health and safety risks far outweigh benefits.

Antidepressants Do Not Prevent Suicides, May Increase Risk

9
When the CDC released data revealing an increasing suicide rate in the US, some experts, speaking to major media outlets, speculated that the increase...

Cognitive-Behavioral Therapy Halves the Risk of Repeated Suicide Attempts

7
A new study suggests that cognitive-behavioral therapy (CBT) may halve the likelihood of re-attempting suicide, for those who have attempted in the past.

Mental Health Concerns Not “Brain Disorders,” Say Researchers

55
The latest issue of the journal Behavioral and Brain Sciences features several prominent researchers arguing that mental health concerns are not “brain disorders.”

Psychiatry Defends Its Antipsychotics: A Case Study of Institutional Corruption

153
Jeffrey LIeberman and colleagues have published a paper in the American Journal of Psychiatry stating that there is no evidence that psychiatric drugs cause long-term harm, and that the evidence shows that these drugs provide a great benefit to patients. A close examination of their review reveals that it is a classic example of institutional corruption, which was meant to protect guild interests.

Rigorous Study Finds Antidepressants Worsen Long-Term Outcomes

37
A new study conducted by Jeffrey Vittengl at Truman University has found that taking antidepressant medications resulted in more severe depression symptoms after nine years.

Researchers Set the Record Straight on Controversial Zoloft Study

1
An issue of Lancet Psychiatry is devoted to clarifying the lack of efficacy for Zoloft (sertraline).

Very Slow Tapering Best For Antidepressant Withdrawal

9
A new article in Lancet Psychiatry finds that slower tapering of SSRIs is better for preventing antidepressant withdrawal effects.

Fighting for the Meaning of Madness: An Interview with Dr. John Read

17
Akansha Vaswani interviews Dr. John Read about the influences on his work and his research on madness, psychosis, and the mental health industry.

Antidepressants Increase Risk of Death, Study Finds

2
Antidepressants are commonly considered safe and effective treatments. However, research has questioned their efficacy, and now, their safety.
twins

Bad-Science Warning: The “Minnesota Study of Twins Reared Apart” (MISTRA)

7
The huge impact of the MISTRA, in addition to the harmful and regressive social and political policy implications that flow from it, necessitates a detailed analysis of the “science” behind the study’s major claims and conclusions. Here I offer a new critique of this famous and influential “separated twin study.”

No Brain Connectivity Differences Between Autism, ADHD, and “Typical Development”

38
Neuroscience researchers find no differences in brain connectivity between children with diagnoses of autism, ADHD, and those with no diagnoses.

The Reckoning in Psychiatry Over Protracted Antidepressant Withdrawal

19
Medically-induced harm—affecting tens of millions of people worldwide—has taken the field decades to take seriously.

What is the Evidence for Empirically Supported Treatments in Psychology?

11
New meta-scientific review questions the evidence for the gold standard psychotherapies and empirically supported treatments.
deep brain stimulation

Brain Implants: Spinning the Trial Results to Protect the Product

39
The published report of the Broaden Trial of Deep Brain Stimulation for Depression whitewashed the results: although the efficacy results were negative, the investigators concluded that the therapy still showed "promise", and adverse events suffered by the patients were downplayed or attributed to the disease, and not the treatment. An in-depth investigation of how the trial results were spun, and interviews with patients that tell of harm done.

Researchers Expose Pharmaceutical Industry Misconduct and Corruption

8
Corruption of pharmaceutical industry sponsored clinical trials identified as a “major obstacle” facing evidence-based medicine.

Review Finds FDA Approval of Digital Antipsychotic Misguided

8
The approval of the digital antipsychotic may open the door for more pharmaceutical company profits without evidence of benefits to patients.

Multiple Researchers Examining the Same Data Find Very Different Results

5
A new study demonstrates how the choice of statistical techniques when examining data plays a large role in scientific outcomes.

Confessions of a Trespasser

166
In a recently published commentary in Psychiatric Times, Ronald Pies and Joseph Pierre made this assertion: Only clinicians, with an expertise in assessing the research literature, should be weighing in on the topic of the efficacy of psychiatric drugs. They wrote their commentary shortly after I had published on madinamerica “The Case Against Antipsychotics,” and it was clear they had me in their crosshairs.

New Study Concludes that Antidepressants are “Largely Ineffective and Potentially Harmful”

7
A new study published in Frontiers in Psychiatry concludes that “antidepressants are largely ineffective and potentially harmful.”

Researchers Question the Utility of an ADHD Diagnosis

16
A new article examines the usefulness of the ADHD diagnosis and suggests alternatives

Johnson & Johnson: 170 Years of Scandal and Fraud

1
-Highlights of Johnson & Johnson's many "decades of fraud and injury claims" in its pharmaceutical-related activities.

Antidepressant Use Linked to Longer, More Frequent Psychiatric Rehospitalization

6
New study finds that antidepressants may negatively impact recovery after psychiatric hospitalization.
christ

Thou Shall Not Criticize Our Drugs

51
A medical journal is expected to promote an open-minded discussion of treatments, even if findings—or criticisms—threaten conventional beliefs. But the American Journal of Psychiatry will not find space for criticism even if it comes from one of the best-known psychiatrists in the world.